The U.S. District Court for the Southern District of New York March 29 certified a plaintiff class of investors in a securities suit against Pfizer Inc. (PFE) and five executives over their alleged concealment of the results of studies of its drugs Celebrex and Bextra (In re Pfizer Inc. Securities Litigation).
Judge Laura Taylor Swain also certified a subclass of persons who purchased stock contemporaneously with sales of Pfizer stock by the individual defendants on certain dates.
According to the court, lead plaintiff Teachers’ Retirement System of Louisiana sued on behalf of all persons who purchased or acquired ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.